Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Muscle Nerve. 2022 Jan 22;65(5):593–598. doi: 10.1002/mus.27484

Table 2-.

Comparison of comorbidities and laboratory and anthropomorphic variables in diabetic (LRPN vs controls) and non-diabetic (LRPN vs controls) patients

Variables Diabetic LRPN
n=39
Diabetic Controls
n=35
p
Yes, N % Yes, N %
Diabetic microvascular complications 18 46 16 46 0.887
Amputation 2 5 1 3 0.621
Hypertension 28 72 26 74 0.81
Dyslipidemia 27 69 24 69 0.951
Stroke 4 10 3 9 0.805
Obesity 24 62 17 49 0.276
Dementia 3 8 1 3 0.358
Comorbid auto disorder 6 15 2 6 0.181
Median range Median range
DM duration, years 8.5 0-41 10 1-50 0.753
Fasting glucose, mg/dl 163 41-430 143 99-291 0.409
HbA1c, % 7.6 5.2-12.5 6.6 5.4-10.7 0.074
BMI, kg/m2 33.3 18.4-57.5 31.2 16.1-47.7 0.132
Weight, kgs 98 53-172 85 42-152 0.072
Variables Non-diabetic LRPN
n=20
Non-diabetic
Controls
n=142
p
Yes, N % Yes, N %
Hypertension 10 50 53 37 0.323
Pre-diabetes 10 50 55 38.7 0.336
Dyslipidemia 12 60 48 34 0.028
Stroke 4 20 4 2.8 0.009
Obesity 7 35 47 33 0.965
Dementia 1 5 1 1 0.232
Comorbid auto disorder 3 15 9 6 0.171
Median range Median range
BMI, kg/m2 29.4 21.0-52.1 27.4 16.1-46.2 0.345
Weight, kgs 87 53-140 79 38-181 0.35

LRPN- lumbosacral radiculoplexus neuropathy; DM- diabetes mellitus; Comorbid auto disorder- comorbid autoimmune disorder; BMI- body mass index; kgs- kilograms.